High expression of the Met receptor in prostate cancer metastasis to bone (Q34163761)

31 July 2017

High expression of the Met receptor in prostate cancer metastasis to bone (English)

1 reference

31 July 2017

1 reference

1 reference

Beatrice S Knudsen

1

1 reference

31 July 2017

Glenn A Gmyrek

2

1 reference

31 July 2017

Jennifer Inra

3

1 reference

31 July 2017

Douglas S Scherr

4

1 reference

31 July 2017

E Darracott Vaughan

5

1 reference

31 July 2017

David M Nanus

6

1 reference

31 July 2017

Michael W Kattan

7

1 reference

31 July 2017

William L Gerald

8

1 reference

31 July 2017

George F Vande Woude

9

1 reference

31 July 2017

language of work or name

English

0 references

publication date

1 December 2002

1 reference

31 July 2017

1 reference

31 July 2017

60

1 reference

31 July 2017

6

1 reference

31 July 2017

1113-1117

1 reference

Hepatocyte growth factor is a coupling factor for osteoclasts and osteoblasts in vitro.

31 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901954-4

7 January 2021

Normal and malignant prostate epithelial cells differ in their response to hepatocyte growth factor/scatter factor

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901954-4

7 January 2021

c-met proto-oncogene expression in benign and malignant human prostate tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901954-4

7 January 2021

Progression-linked overexpression of c-Met in prostatic intraepithelial neoplasia and latent as well as clinical prostate cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901954-4

7 January 2021

Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901954-4

7 January 2021

Invasiveness and metastasis of NIH 3T3 cells induced by Met-hepatocyte growth factor/scatter factor autocrine stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901954-4

7 January 2021

Role of the hepatocyte growth factor receptor, c-Met, in oncogenesis and potential for therapeutic inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901954-4

7 January 2021

E-cadherin expression as a marker of tumor aggressiveness in routinely processed radical prostatectomy specimens

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901954-4

7 January 2021

The biology of hormone refractory prostate cancer. Why does it develop?

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901954-4

7 January 2021

Constitutive expression of HGF modulates renal epithelial cell phenotype and induces c-met and fibronectin expression.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901954-4

7 January 2021

Osteomimetic properties of prostate cancer cells: a hypothesis supporting the predilection of prostate cancer metastasis and growth in the bone environment

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901954-4

7 January 2021

10.1016/S0090-4295(02)01954-4

Identifiers

DOI

1 reference

31 July 2017

1 reference